Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Lowering testosterone speeds up wound healing in male mice.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Mutations in certain receptors can cause diseases and offer new treatment options.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Acne is an important sign of androgen excess disorders in women.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.